Campo DC | Valor | Idioma |
dc.contributor.author | AGARWAL, NEERAJ | - |
dc.contributor.author | AZAD, ARUN | - |
dc.contributor.author | SHORE, NEAL D | - |
dc.contributor.author | CARLES, JOAN | - |
dc.contributor.author | André Poisl Fay | - |
dc.contributor.author | DUNSHEE, CURTIS | - |
dc.contributor.author | KARSH, LAWRENCE IVAN | - |
dc.contributor.author | PACCAGNELLA, MARIA LUISA | - |
dc.contributor.author | SANTO, NICOLA DI | - |
dc.contributor.author | ELMELIEGY, MOHAMED | - |
dc.contributor.author | LIN, XUN | - |
dc.contributor.author | CZIBERE, AKOS | - |
dc.contributor.author | FIZAZI, KARIM | - |
dc.date.accessioned | 2023-03-29T18:13:06Z | - |
dc.date.available | 2023-03-29T18:13:06Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1479-6694 | - |
dc.identifier.uri | https://hdl.handle.net/10923/23945 | - |
dc.language.iso | en | - |
dc.relation.ispartof | Future Oncology | - |
dc.rights | openAccess | - |
dc.title | Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancer | - |
dc.type | Article | - |
dc.date.updated | 2023-03-29T18:13:05Z | - |
dc.identifier.doi | DOI:10.2217/fon-2022-0389 | - |
dc.jtitle | Future Oncology | - |
dc.volume | 18 | - |
dc.issue | 27 | - |
dc.spage | 2979 | - |
dc.epage | 2986 | - |
Aparece en las colecciones: | Artigo de Periódico
|